How long should you meditate? What the research shows

Almost every meditation app, book and teacher will give you a number. Ten minutes. Twenty minutes, twice a day. Forty-five minutes of formal home practice, six days a week. The numbers are specific, they are confidently stated, and they are repeated everywhere.

We went looking for the studies behind them. (If you just want a session at a specific length, the meditation script generator will build one.)

What we found is a small, honest, and much more interesting body of evidence than the confidence of those numbers suggests. Six controlled experiments have deliberately varied how long people meditate. The most-repeated prescription in modern mindfulness is reported to have been chosen on an intuition. And the largest datasets point at something other than minutes entirely.

The short answer

If you want the honest one-line version: research has not established an optimal meditation session length. In beginners, randomised evidence through July 2026 does not show that prescribing 20 or 30 minutes produces reliably better outcomes than practising for 5 or 10. Practice frequency and follow-through look at least as important, though most of the evidence for those is observational rather than experimental.

That is not the same as saying length does not matter. It is a narrower and more accurate claim: the experiment that would establish an optimal length has barely been run.

The gap between how much meditation research exists and how much of it addresses dose is the central fact of this article. Many hundreds of trials have asked whether meditation works. Almost none have asked how much of it you need.

What has actually been tested

Six trials have randomly assigned people to different session lengths. Here is every one of them.

Read that table twice, because two different mistakes are easy to make from it.

The first mistake is concluding that length is irrelevant. It does not show that. Most of these were superiority trials, designed to detect a difference if one existed. They were not equivalence trials, which are designed to demonstrate that two doses are genuinely interchangeable. Failing to find a difference is not the same as proving there is none, particularly when samples are small.

The second mistake is dismissing the null results as underpowered noise. Some of them are reasonably informative. Fincham and colleagues had 161 completers and about 75% power, which makes a missed medium effect unlikely, though not impossible.

The studies do not all agree

It would be tidy if all six said the same thing. They do not, and the disagreements are informative.

Strohmaier and colleagues in 2021 found the shorter condition producing greater gains than the longer one, on both trait mindfulness and stress. Palmer and colleagues found an exploratory advantage for 20 minutes on anxiety, but only among participants already high in trait mindfulness. The 2026 single-session trial found that both doses increased curiosity, while only the 20-minute condition separated from control on decentering.

These are outcome-specific and subgroup-specific findings. They are not a general optimum, and none of them should be converted into a recommendation.

The newest and largest trial

The 2026 preprint by Bowles and colleagues is the closest thing to a proper test that exists. It randomised 716 meditation-naive adults across four daily doses for 28 days, the shortest of which (4 minutes) served as a minimally active control, which addresses most of the weaknesses in the older studies at once: adequate sample, multiple arms, daily practice and a multi-week window.

Every arm improved. None improved more than any other on the basis of assigned dose.

Where the numbers came from

The 45 minutes in MBSR

Mindfulness-Based Stress Reduction asks participants to practise formally for around 45 to 60 minutes a day, six days a week, for eight weeks. It is the most influential dose prescription in modern mindfulness, and it appears in hundreds of clinical trials.

In interview material reproduced in Bowles and colleagues’ 2026 review, Jon Kabat-Zinn is quoted as saying that 45 minutes seemed long enough to settle into stillness and sustained attention, and describing the choice as a good intuition.

We flag the sourcing chain deliberately. We have not verified those words against a primary text by Kabat-Zinn himself, so we report them as the review reports them, at one remove. If you are citing this, cite the review.

That is not a criticism of MBSR, and it is important not to read it as one. MBSR was designed as an intensive, coherent training package, and the clinical evidence for that package is genuinely strong. The point here is narrower and specific: 45 minutes was not the winning arm of a dose-ranging trial. Nobody compared it to 20 or 30 and found it superior.

Worth noting too that Full Catastrophe Living contains both things at once. It sets out the intensive clinical prescription, and it also says plainly that even five minutes can be restorative and that practising daily matters more than the time on the clock.

The honest finding is that the programme was shortened during its early development. Not that eight weeks was empirically optimised.

Twenty minutes, twice a day

This is the Transcendental Meditation prescription, and current official TM materials state it directly.

In the accessible 1963/1966 edition of Maharishi Mahesh Yogi’s The Science of Being and Art of Living, the instruction we located is to meditate for a few minutes morning and evening. That supports the twice-daily rhythm. It does not support the fixed 20-minute figure.

No dose-finding experiment or originator statement explaining why exactly 20 minutes was chosen turned up in this search. The number may have been standardised in later teaching materials. Its provenance is unresolved.

The 10-minute app session

Headspace’s early Take10 product and Andy Puddicombe’s 2012 TED talk, titled “All it takes is 10 mindful minutes,” made this a highly visible consumer unit. Calm’s daily content has commonly used a similar length.

We found no published app experiment, patent or founder statement indicating that 10 minutes was selected because it maximised clinical effect. The available evidence supports a product-design explanation, built around accessibility and repeatability, rather than a biological optimum. It would also be an overclaim to say Headspace invented the norm.

What the health bodies say

This is the part that surprised us most. Not one reviewed body sets a universal, experimentally derived meditation dose.

The VA’s own materials put it about as plainly as a public body can: how much routine practice is needed each day or week is not entirely clear.

That absence matters. Public health has a number for physical activity, the familiar 150 minutes a week, because the dose-response evidence for exercise was deliberately built over decades of large cohort studies with hard endpoints. Meditation has no equivalent because the equivalent research programme has not been run.

Assigned dose vs received dose

Here is the distinction that reorganises this entire question, and it is the one most consumer articles skip.

Assigned dose is what a study tells people to do. Received dose is what they actually do. These are different numbers, and almost everything we know about meditation length is measured on the first one.

The gap is large and it is well documented.

This creates a genuine tension. If participants in MBSR trials completed roughly two thirds of a 45-minute prescription, then the dose that produced those celebrated clinical results was closer to 30 minutes than 45. The prescription and the evidence are not describing the same quantity.

It does not follow that the prescription was unnecessary. People who complete more homework may differ systematically from people who complete less, in motivation, circumstances, or early response. Treatment effects are estimated by assignment precisely because assignment is the thing that was randomised. But it does mean that quoting 45 minutes as an evidence-based dose overstates what the trials actually tested.

There is also a suggestion, from the largest multi-arm trial, that raising the prescription can lower the delivery. Across the 10, 20 and 30-minute arms of the 2026 preprint, completion fell as assigned dose rose while outcomes stayed flat. The 4-minute arm’s completion figure was not available to us, so the trend is stated across three arms, not four. If that survives peer review, it is the practical heart of this whole question: a longer prescription can buy you less practice, not more.

Does consistency beat length?

This is the most repeated claim in the space, and it is closer to true than most, but it needs qualifying.

The strongest evidence comes from an analysis of 289,630 logged meditation sessions across 103 countries by Cearns and Clark, published in the Journal of Medical Internet Research in 2023.

In the same dataset, frequency did predict something. People practising four to seven days a week were 2.33 times as likely to reach their 150th session as people practising one day a week. Morning practitioners were 2.1 times as likely, with a smaller daytime advantage that did not survive correction for multiple comparisons.

Note carefully what those odds ratios predict: reaching a later session, which is persistence, not symptom improvement. Practising in the morning was associated with still practising later. It was not shown to make each session more effective.

And there is a direct experimental test that complicates the slogan. Riordan and colleagues in 2024 randomised 351 distressed undergraduates to either one 20-minute practice or two 10-minute practices per day, holding the daily total constant. Both groups improved. Neither beat the other, with between-group effects of d = .01 to .16.

So splitting the same total across more sessions did not help. The honest formulation is that frequency and follow-through are more reliable predictors than session length in several large datasets, and that this has not been demonstrated as a universal causal law.

What people actually do

If received dose is what matters, then real-world engagement data is the most relevant evidence there is. It is also where the worst statistics in this field circulate.

A 2026 longitudinal study of Medito users gives the cleanest first-month picture available. Among 655 users with objective usage data, median total use across the first 30 days was 16.11 minutes. Not per day. In total.

That last figure deserves a note. Attrition in Linardon’s meta-analysis was 24.7% overall but projected at 38.7% in trials with at least 100 participants per condition. Small efficacy trials tend to recruit more motivated volunteers and provide more contact, so they understate real-world dropout. The bigger the trial, the worse the retention looks.

The first month is only the opening of the curve. A longitudinal analysis of 2,600 new annual subscribers to Calm found that 83.1% used the app at least once after their initial period, but 58.0% of that cohort had abandoned it by day 350. What the people who stayed actually did is the more useful number. Among persistent users, practice averaged 0.33 sessions and 3.93 meditation minutes per day, counting every day rather than only practice days. Calm supplied the data for that study and several of its authors held research relationships with the company.

Step back from any single app and the picture is similar. A panel analysis of 93 Android mental health apps estimated a median day 30 retention of 4.7% across the 26 classed as mindfulness or meditation, with use declining by more than 80% between days 1 and 10. That number circulates widely and is almost always quoted wrongly. It is a category median drawn from a 2017 to 2018 Android panel, not the retention rate of any named app, and the panel’s own sample size was never disclosed.

This is also why momentum matters more than any single session. Self-report makes all of this look better than it is. In a 2026 cross-sectional survey, median self-reported use was 3.29 sessions and 40.25 minutes per month. In the subset where use could be objectively verified, the medians were 0.66 sessions and 10.61 minutes.

That is the real problem with retention statistics in this field. The numbers people quote side by side are not measuring the same thing.

Where the evidence disagrees

An article that only presented the findings above would be tidy and slightly dishonest. There is real evidence pointing the other way, and it deserves a proper hearing.

The pattern is consistent and worth stating explicitly. The experimental evidence has not detected a dose-response. The observational evidence often does, and points at much higher daily doses than any app default.

Both can be true at once, and the reason is straightforward. In observational data, nobody assigns the dose. People choose it. Someone practising 50 minutes a day is different from someone practising 10, in ways that plausibly affect wellbeing independently of meditation: available time, life stability, health, motivation, and how much the practice is already working for them. Randomisation exists precisely to break that link, and when researchers do randomise, the dose effect largely disappears.

That does not make the observational studies worthless. It makes them hypothesis-generating. If the higher ranges are real, current trials may simply be testing doses too low and windows too short to detect the effect.

Three reasons the two literatures pull apart

They are not testing the same range. Every randomised duration experiment we could find assigns somewhere between 4 and 30 minutes a day. The prospective estimates begin at 35. Read side by side, the largest dose anyone has randomised sits below the smallest dose the observational work associates with benefit. On that reading the two bodies of evidence may not be contradicting each other so much as failing to meet. This is our own comparison of the two literatures, not a claim made by either set of authors, and it is offered as a question worth testing rather than a conclusion.

They are asking different questions. Parsons and colleagues ask whether people who practise more within an intervention tend to improve more. Strohmaier asks whether trials prescribing larger average doses produce larger effects. Those are two different questions with two different failure modes, and a pattern that holds across studies need not hold inside any one of them.

The observational estimates are less stable than they look. They rest on self-reported practice, and in the one population where both were measured, self-report ran roughly four times higher than the objective records. They are also model-dependent. In the cross-sectional lifetime-hours analysis, the practice estimated to produce a clinically meaningful difference shifts substantially depending on which outcome is modelled, which is reason enough to treat any single headline number from this literature as provisional.

Nine claims, checked

These nine statements circulate widely. We traced each to its origin. Several do not survive the trip.

Methodology and glossary

How we sourced this

Claims are graded by the strength of the evidence behind them, using four tiers. Tier 1 is peer-reviewed primary research, systematic reviews, meta-analyses, government bodies and clinical guidelines. Tier 2 is established polling organisations and academic think tanks with transparent methods. Tier 3 is market-research firms, used directionally only. Tier 4 is corporate self-reports and product documentation, always labelled as company-reported. Preprints are labelled as not peer reviewed. This is the same hierarchy we apply in our meditation statistics report, which covers adoption, market and clinical evidence rather than dose.

Where a figure could not be traced to a primary source, it is excluded and listed in the claim audit above rather than repeated.

The distinctions that matter

Most confusion in this area comes from treating these as interchangeable. They are not.

A study showing that eight weeks of 13-minute sessions helped does not establish that 13 minutes is the minimum. A correlation between actual practice and outcome does not show that assigning more minutes would improve outcome. Most of the bad statistics in this field come from collapsing one of these into another.

The dataset

The evidence table in this article is published as reusable data under CC BY 4.0, alongside a machine-readable summary of the key dose and adherence figures. Every entry is traceable to a named primary source. Figures that could not be confirmed from the primary text are marked rather than estimated, nothing is inferred or back-calculated, and figures from the unpublished preprint are excluded from the machine-readable summary entirely.

Murphy, J. (2026). How long should you meditate? What the research shows. StillMind. https://getstillmind.com/blog/how-long-should-you-meditate/

@techreport{murphy2026meditationdose,
  title  = {How long should you meditate? What the research shows},
  author = {Murphy, Jamie},
  year   = {2026},
  institution = {StillMind},
  url    = {https://getstillmind.com/blog/how-long-should-you-meditate/}
}

What to actually do

Research that refuses to give you a number is not much use on a Tuesday morning. So here is a practical position, clearly labelled as what it is: a pragmatic recommendation, not an evidence-derived dose.

Start at a length you are confident you will repeat tomorrow. For most people beginning, that is somewhere between five and ten minutes, which is why our 5-minute scripts and 10-minute scripts exist as separate collections. Not because the evidence identifies it as optimal, but because it does not identify anything as optimal, and among the options that are equally supported, the one you will actually do is the one worth choosing. If you are starting from scratch, our beginners guide walks through the first few weeks.

Then hold the length steady and let frequency do the work. The strongest signals in the largest datasets are about practising on more days, about practising earlier in the day, and about having a stable cue that tells you when it happens. A meditation timer handles the cue, and there is a short guide to setting one up, and keeping a journal is what makes your own pattern visible over weeks rather than guessed at. Those findings are observational and they predict persistence rather than symptom change, so hold them loosely. But they are the closest thing to a durable pattern in this literature.

Extend the session when the current length starts feeling short rather than long, and note that a timer and a guided session suit different stages of that. There is some suggestion, in the nonlinear observational data, that longer sessions become more useful later rather than earlier, which fits what teachers have said for a long time.

If your practice has already lapsed, the length question matters less than the restarting question. And treat any specific number you encounter, including the ones in this article, as a starting point rather than a target. Across this literature the differences between doses are consistently smaller than the differences these practices show against not practising at all, though it is worth noting most of these trials used an active or time-matched control rather than a non-practising one.

FAQ